MedTrace Logo

Optimizing Strategies to Maximize Patient Recruitment Yield

NCT07290335 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100000

Last updated 2026-02-25

No results posted yet for this study

Summary

This platform trial aims to evaluate the effectiveness of different messaging strategies within a MyChart messaging program for research recruitment. MyChart is a patient portal system within the Electronic Medical Record (EMR), and messages can be sent directly to patients about research opportunities.

Conditions

  • Recruitment

Interventions

BEHAVIORAL

Baseline (control) message

The MyChart study recruitment program will send a message based on the current template, which is a brief message with a neutral tone.

BEHAVIORAL

Positively-valenced message

The MyChart study recruitment program will send a message based on a template that contains positively-valenced language related to the value/importance of the study.

BEHAVIORAL

Payment-inclusive message

The MyChart study recruitment program will send a message based on a template that includes more detailed information about participant payment.

BEHAVIORAL

Positively-valenced, payment-inclusive message

The MyChart study recruitment program will send a message based on a template that includes both positively-valenced language and detailed information about participant payment.

Sponsors & Collaborators

  • American Heart Association

    collaborator OTHER

  • Georgia Clinical and Translational Science Alliance (GaCTSA)

    collaborator UNKNOWN

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • Emory University

    lead OTHER

Principal Investigators

  • Neal Dickert, MD, PhD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-19
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07290335 on ClinicalTrials.gov